Elevated levels of testosterone receptors in keloid tissue: an experimental investigation
- PMID: 9252606
- DOI: 10.1097/00006534-199708000-00017
Elevated levels of testosterone receptors in keloid tissue: an experimental investigation
Abstract
Testosterone-binding receptor protein analyses were performed in keloids of 24 patients. According to their clinical appearance (hyperemia, pain, rapid growth, etc.), the lesions were subdivided into regions of minor and major clinical keloid activity. Biopsies were taken from active and inactive parts of the keloids, respectively, as well as from normal adjacent skin. The mean receptor amount in femtomoles per milligrams of tissue was 0.046 for active (SD = 0.037), 0.038 for inactive keloidal lesions (SD = 0.032), and 0.012 for normal skin. The corresponding receptor amount per microgram of DNA was 3.356 fmol (SD = 2.171) for active, 2.077 fmol (SD = 1.427) for inactive keloidal, and 1.010 fmol (SD = 1.190) for normal tissue. Statistical evaluation was performed using a two-way analysis of variance, with the two factors being individual subject and type of tissue. When differences were found, then Tukey's comparison was done to assess where those differences were. Comparisons of the receptor amount per milligram of tissue significant at the 0.05 level revealed significant differences between active keloid tissue and normal skin tissue and inactive and normal tissue (p < 0.01) respectively, while different receptor amount per microgram of DNA was significant between active and inactive and active and normal tissue (p < 0.01). These data suggest that elevated androgen receptor levels exist in clinical active keloid tissue and that possible therapeutic means might include topical antiandrogen therapy.
Similar articles
-
Increased expression of tenascin C by keloids in vivo and in vitro.Br J Dermatol. 1999 Jul;141(1):50-6. doi: 10.1046/j.1365-2133.1999.02920.x. Br J Dermatol. 1999. PMID: 10417515
-
Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.Plast Reconstr Surg. 2001 Aug;108(2):423-9. doi: 10.1097/00006534-200108000-00022. Plast Reconstr Surg. 2001. PMID: 11496185
-
Keloids show regional distribution of proliferative and degenerate connective tissue elements.Cells Tissues Organs. 2010;191(3):213-34. doi: 10.1159/000231899. Epub 2009 Jul 29. Cells Tissues Organs. 2010. PMID: 19641294
-
Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.J Invest Dermatol. 2000 May;114(5):953-9. doi: 10.1046/j.1523-1747.2000.00950.x. J Invest Dermatol. 2000. PMID: 10771477
-
Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.Int J Mol Sci. 2017 Mar 10;18(3):606. doi: 10.3390/ijms18030606. Int J Mol Sci. 2017. PMID: 28287424 Free PMC article. Review.
Cited by
-
Prevention and treatment of excessive dermal scarring.J Natl Med Assoc. 2004 Jan;96(1):108-16. J Natl Med Assoc. 2004. PMID: 14746360 Free PMC article. Review.
-
[Weighted gene co-expression network analysis of methylated genes in burn scar tissue].Zhonghua Shao Shang Za Zhi. 2021 Dec 20;37(12):1185-1190. doi: 10.3760/cma.j.cn501120-20200311-00150. Zhonghua Shao Shang Za Zhi. 2021. PMID: 34839606 Free PMC article. Chinese.
-
A pregnant patient with fetal distress with severe post burn contracture of anterior trunk and perineum: A surgeon's nightmare!Indian J Plast Surg. 2014 Sep-Dec;47(3):456-9. doi: 10.4103/0970-0358.146674. Indian J Plast Surg. 2014. PMID: 25593442 Free PMC article.
-
Eruptive keloids associated with aromatase inhibitor therapy.JAAD Case Rep. 2015 May 2;1(3):112-3. doi: 10.1016/j.jdcr.2015.01.008. eCollection 2015 May. JAAD Case Rep. 2015. PMID: 27051701 Free PMC article. No abstract available.
-
An Update on Molecular Mechanisms of Scarring-A Narrative Review.Int J Mol Sci. 2024 Oct 28;25(21):11579. doi: 10.3390/ijms252111579. Int J Mol Sci. 2024. PMID: 39519131 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources